Inventor · disambiguated record
Matthew Albert
Also filed as: ALBERT MATTHEW · ALBERT MATTHEW L · ALBERT MATTHEW LAWRENCE
13 granted patents·8 pending applications·74 citations·filing 1999–2024
87Inventor score
Top patents by PatentIndex Score
21 records- 0186US6602709B1Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cellsUNIV ROCKEFELLER·Filed 1999·Granted Aug 5, 2003·61 cites·26 claims
- 0284US7989203B2Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cellsUNIV ROCKEFELLER·Filed 2006·Granted Aug 2, 2011·2 cites·9 claims
- 0376US2024100048A1Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyPASTEUR INSTITUT·Filed 2023·Application pending·0 cites
- 0476US2025061965A1Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 0571US11883398B2Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyPASTEUR INSTITUT·Filed 2021·Granted Jan 30, 2024·0 cites·21 claims
- 0669US2024018241A1Anti-cd8 antibodies and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 0767US12183434B2Diagnostic and therapeutic methods for cancerGENENTECH INC·Filed 2021·Granted Dec 31, 2024·0 cites·21 claims
- 0866US6750029B1Methods and agents for the detection and modulation of cellular immunity to immune privileged antigensUNIV ROCKEFELLER·Filed 2000·Granted Jun 15, 2004·7 cites·24 claims
- 0965US11229645B2Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyPASTEUR INSTITUT·Filed 2020·Granted Jan 25, 2022·0 cites·6 claims
- 1062US7129037B2Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cellsUNIV ROCKEFELLER·Filed 2001·Granted Oct 31, 2006·1 cites·6 claims
- 1160US8124332B2Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infectionsALBERT MATTHEW·Filed 2009·Granted Feb 28, 2012·3 cites·10 claims
- 1258US11000521B2Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyPASTEUR INSTITUT·Filed 2015·Granted May 11, 2021·0 cites·4 claims
- 1356US11739150B2Anti-CD8 antibodies and uses thereofGENENTECH INC·Filed 2020·Granted Aug 29, 2023·0 cites·25 claims
- 1451US10254282B2Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDSPASTEUR INSTITUT·Filed 2016·Granted Apr 9, 2019·0 cites·17 claims
- 1551US9523687B2Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDSPASTEUR INSTITUT·Filed 2014·Granted Dec 20, 2016·0 cites·8 claims
- 1647US7674578B2Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapyPASTEUR INSTITUT·Filed 2007·Granted Mar 9, 2010·0 cites·5 claims
- 1746US2006110371A1Control of indoleamine 2,3 deoxygenase expression and activityPASTEUR INSTITUT·Filed 2005·Application pending·0 cites
- 1844US2002004041A1Methods for abrogating a cellular immune responseFiled 2001·Application pending·0 cites
- 1943US2012171158A1METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONSALBERT MATTHEW·Filed 2012·Application pending·0 cites
- 2041US2015071873A1Cancer Treatment by Immunotherapy With BCG or Antigenically Related Non-Pathogenic MycobacteriaPASTEUR INSTITUT·Filed 2013·Application pending·0 cites
- 2140US2003072743A1Genetic manipulation of phagocytes for modulation of antigen processing and the immune response therefromFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Albert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →